Valiance Health

Founded in 2025, Valiance Health Sdn. Bhd. operates from Kuala Lumpur, Malaysia, focusing on innovative healthcare solutions. In February 2026, Valiance Health Sdn.

Bhd. raised an amount of pre-seed funding led by Gobi Partners, with participation from Artem Ventures and Jati Growth. Valiance Health focuses on providing innovative healthcare solutions that leverage advanced technology to enhance patient care and streamline operational efficiencies. The company's flagship offerings include a suite of AI-driven tools designed to optimize clinical workflows, improve patient outcomes, and facilitate data-driven decision-making for healthcare providers.

These products are intended to address challenges such as patient management, resource allocation, and treatment personalization in various healthcare settings. Valiance Health's client base encompasses hospitals, clinics, and other healthcare organizations, primarily in North America and Europe, all aiming to transform their patient care processes through the adoption of technology. The company supports end-users, including healthcare professionals and patients, by making healthcare delivery more efficient and responsive to individual needs. Valiance Health generates revenue through a structured model that integrates subscription-based services and partnerships with healthcare providers.

Clients typically engage in contracts that encompass annual subscriptions for access to the company's software solutions, which may include ongoing support and updates. Revenue from these transactions is bolstered by partnerships with larger healthcare systems. The company’s pricing plans are structured to encourage scalable adoption, catering to both small clinics and large hospital networks, ensuring that clients can choose the level of service that best meets their operational requirements. This revenue model positions Valiance Health as a key player in the healthcare technology market, providing essential services that drive efficiency and quality in patient care.

The company plans to use the February 2026 funding to support team expansion, strengthen artificial intelligence-driven standardization pipelines, deepen system integrations, and scale collaborations with insurers and administrators.